Constrained Peptide Drugs - Global Forecast 2024-2030

by Peptide Type (Macrocyclic, Stapled), End-User (Hospitals & Clinics, Pharmaceutical Companies)

Published	Pages	Publisher	Report code
Jan 2024	187	360 iResearch	ASDR-646502

Published: Jan 2024 - Pages : 187 - Publisher : 360 iResearch - Report code : ASDR-646502

1. Bicycle Therapeutics Inc.
2. Biosynth Ltd
3. IRBM S.p.A.
4. PeptiDream Co. Ltd.
5. Pfizer Inc.
6. Protagonist Therapeutics Inc.
7. UCB S.A